BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11245437)

  • 1. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
    Gökmen-Polar Y; Murray NR; Velasco MA; Gatalica Z; Fields AP
    Cancer Res; 2001 Feb; 61(4):1375-81. PubMed ID: 11245437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
    Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW
    Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
    Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
    Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphodensitometric analysis of protein kinase C beta(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis.
    Davidson LA; Brown RE; Chang WC; Morris JS; Wang N; Carroll RJ; Turner ND; Lupton JR; Chapkin RS
    Carcinogenesis; 2000 Aug; 21(8):1513-9. PubMed ID: 10910952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis.
    Murray NR; Davidson LA; Chapkin RS; Clay Gustafson W; Schattenberg DG; Fields AP
    J Cell Biol; 1999 May; 145(4):699-711. PubMed ID: 10330400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
    Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors.
    Dai W; Liu T; Wang Q; Rao CV; Reddy BS
    Int J Oncol; 2002 Jan; 20(1):121-6. PubMed ID: 11743651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer.
    Davidson LA; Aymond CM; Jiang YH; Turner ND; Lupton JR; Chapkin RS
    Carcinogenesis; 1998 Feb; 19(2):253-7. PubMed ID: 9498273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the role of protein kinase C isozymes in colon carcinogenesis using transgenic mouse models.
    Fields AP; Murray NR; Gustafson WC
    Methods Mol Biol; 2003; 233():539-53. PubMed ID: 12840533
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
    Hu Y; Le Leu RK; Young GP
    Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azoxymethane induces KI-ras activation in the tumor resistant AKR/J mouse colon.
    Bolt AB; Papanikolaou A; Delker DA; Wang QS; Rosenberg DW
    Mol Carcinog; 2000 Mar; 27(3):210-8. PubMed ID: 10708483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in protein kinase C in 1,2-dimethylhydrazine induced colonic carcinogenesis.
    Craven PA; DeRubertis FR
    Cancer Res; 1992 Apr; 52(8):2216-21. PubMed ID: 1559225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.